InvestorsHub Logo

glass_half_full

11/17/14 3:08 PM

#56303 RE: gr8db8 #56298

Ariad has not been one to pump/over market their products.


I'm bookmarking this post. It's a keeper.

As for EPIC, this is the FT article:

Investigators had informed the company about the frequency of CV events seen in EPIC, but “Ariad was not listening,” the second source said. Investigators had asked Ariad to reduce Iclusig’s 45 milligram (mg) dose in EPIC, but the company did not do so until after the FDA began its investigation, the first and second sources explained.